Hem › Atopisk dermatit (eksem) › Georgia
Kliniska studier för Atopisk dermatit (eksem) i Georgia
9 studier för Atopisk dermatit (eksem) söker deltagare vid platser i Georgia.
Städer i Georgia
Officiell studietext (engelska)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034, Macon
RekryterarObservationsstudie
Ålder 12 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Atlanta
- Novartis Investigative Site, Macon
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Atlanta
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Douglasville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Hamilton Research, LLC, Alpharetta
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07223697A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Georgia Skin & Cancer Center, Savannah
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 28 aug. 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Emory University School Of Medicine - Atlanta /ID# 268832, Atlanta
- Aeroallergy Research Laboratory /ID# 267247, Savannah
RekryterarFas 3
Ålder 2 till 11 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Macon
RekryterarFas 3
6 Months – 11 Years · Alla kön · Uppdaterad 7 juli 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Centricity Research Columbus Dermatology /ID# 266529, Columbus
- Cleaver Medical Group Dermatology /ID# 263788, Dawsonville
RekryterarFas 3
Ålder 18 till 63 · Alla kön · Uppdaterad 6 juli 2026 · NCT06389136Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.